Lipid-lowering therapy in patients with peripheral arterial disease: Are guidelines being met?

Mayo Clinic Proceedings

Volumn 80, Issue 4, 2005, Pages 494-498

  Federman, Daniel G ^a   Ranani, Dana C ^a   Kirsner, Robert S ^b   Bravata, Dawn M ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BODY WEIGHT; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MEDICAL RECORD; HUMAN; LEG; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRACTICE GUIDELINE;

EID: 16344366890     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.4.494     Document Type: Article

References (21)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
2. Fowkes FG. Epidemiology of peripheral vascular disease. Atherosclerosis. 1997;131(suppl):S29-S31.
3. Rockson SG, Cooke JP. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Intern Med. 1998;43:253-277.
4. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med. 1996;1:60-64.
5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
6. Newman AB, Shemanski L, Manolio TA, et al. Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538-545.
7. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87: 119-128.
8. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg. 1999;12:142-147.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
10. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209-215.
11. Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis, I: background, goals, and general strategy. J Clin Epidemiol. 1995;48:1495-1501.
12. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis, II: accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503-1510.
13. Zhang J, Yu KF. What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690-1691.
14. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
15. Leng GC, Price JF, Jepson RG. Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev. 2000;2:CD000123.
16. Blankenhorn DH, Azen SP, Crawford DW, et al. Effects of colestipolniacin therapy on human femoral atherosclerosis. Circulation. 1991;83:438-447.
17. Lewis B. Randomised controlled trial of the treatment of hyperlipidaemia on progression of atherosclerosis. Acta Med Scand Suppl. 1985; 701:53-57.
18. Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol. 1999; 15:1259-1263.
19. Clark AL, Byrne JC, Nasser A, McGroarty E, Kennedy JA. Cholesterol in peripheral vascular disease - a suitable case for treatment? QJM. 1999;92: 219-222.
20. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286: 1317-1324.
21. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348:2218-2227.